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Abstract
Background: Measuring patient-reported outcomes (PROs) requires an individual’s perspective on their symptoms, functional
status, and quality of life. Digital health enables remote electronic PRO (ePRO) assessments as a clinical decision support tool
to facilitate meaningful provider interactions and personalized treatment.
Objective: This study explored the feasibility and acceptability of collecting ePROs using validated health-related quality of
life (HRQoL) questionnaires for prostate cancer.
Methods: Using Apple ResearchKit software, the Strength Through Insight app was created with content from validated HRQoL
tools 26-item Expanded Prostate Cancer Index Composite (EPIC) or EPIC for Clinical Practice and 8-item Functional Assessment
of Cancer Therapy Advanced Prostate Symptom Index. In a single-arm pilot study with patients receiving prostate cancer treatment
at Thomas Jefferson University Hospital and affiliates, participants were recruited, and instructed to download Strength Through
Insight and complete ePROs once a week over 12 weeks. A mixed methods approach, including qualitative pre- and poststudy
interviews, was used to evaluate the feasibility and acceptability of Strength Through Insight for the collection and care management
of cancer treatment.
Results: Thirty patients consented to the study; 1 patient failed to complete any of the questionnaires and was left out of the
analysis of the intervention. Moreover, 86% (25/29) reached satisfactory questionnaire completion (defined as completion of
60% of weekly questions over 12 weeks). The lower bound of the exact one-sided 95% CI was 71%, exceeding the 70% feasibility
threshold. Most participants self-identified with having a high digital literacy level (defined as the ability to use, understand,
evaluate, and analyze information from multiple formats from a variety of digital sources), and only a few participants identified
with having a low digital literacy level (defined as only having the ability to gather information on the Web). Interviews were
thematically analyzed to reveal the following: (1) value of emotional support and wellness in cancer treatment, (2) rise of social
patient advocacy in online patient communities and networks, (3) patient concerns over privacy, and (4) desire for personalized
engagement tools.
Conclusions: Strength Through Insight was demonstrated as a feasible and acceptable method of data collection for ePROs. A
high compliance rate confirmed the app as a reliable tool for patients with localized and advanced prostate cancer. Nearly all
participants reported that using the smartphone app is easier than or equivalent to the traditional paper-and-pen approach, providing
evidence of acceptability and support for the use of remote PRO monitoring. This study expands on current research involving
the value of digital health, as a social and behavioral science, augmented with technology, can begin to contribute to population
J Med Internet Res 2020 | vol. 22 | iss. 3 | e12689 | p. 1https://www.jmir.org/2020/3/e12689
(page number not for citation purposes)
Tran et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
health management, as it shapes psychographic segmentation by demographic, socioeconomic, health condition, or behavioral
factors to group patients by their distinct personalities and motivations, which influence their choices.
Trial Registration: ClinicalTrials.gov NC03197948; http://clinicaltrials.gov/ct2/show/NC03197948
(J Med Internet Res 2020;22(3):e12689)  doi: 10.2196/12689
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Introduction
Prioritizing Patient-Reported Outcomes
As hospitals seek to provide better value in health care,
patient-reported outcome measures (PROMs), such as those
evaluating pain and distress, are an integral part of improving
care. Patient-reported outcomes (PROs) can serve as an
innovative way for providers to incentivize patients to make
changes that facilitate patient engagement and self-care for
chronic disease management and prevention [1-4]. The use of
PROs for cancer patients is not only appropriate but also is
becoming an increasing unmet need, as studies suggest remote
monitoring has been evaluated and demonstrated to improve
survival. Studies have shown that PROs can lead to improved
patient communication with providers, engagement, satisfaction,
and better health outcomes. PROs can enhance care management
by understanding the impact of treatments on patients’ lives [5].
This is increasingly important in cancer care, as patients with
cancer can experience changes in their nutrition, elimination,
pain management, and sexual function at varying levels of
severity [6]. A health-related quality of life (HRQoL) evaluation
can be imperative to evaluate the results of clinical trials.
However, there is substantial evidence that clinical investigators
miss 40% to 74.4% of patients’ symptomatic adverse events
(AEs) [7]. Moreover, major policy making entities have also
emphasized the importance of incorporating PROs into cancer
research and policy formation (including the National Cancer
Institute [NCI], American Cancer Society, and US Food and
Drug Administration). This interest reflects a growing national
recognition that traditional medical outcomes (ie, survival and
disease progression) do not fully capture the patient’s experience
of health, and there is an unmet need for health care providers
to capture a new definition of value of health care, which
includes improvement in subjective outcomes of importance to
patients [8]. The 2 principal methods of gathering PROs (before
the advent of electronic methodologies) are paper-and-pen
approach and clinician interview, both of which are labor and
time intensive. For PROs to be routinely integrated into clinical
practice, PRO data collection methods must be efficient by
demonstrating convenient, instantaneous, inexpensive, reliable,
and clinically feasible.
A Digital Evolution
With the widespread adoption of smartphones, tablets, and other
smart devices, mobile apps provide a new platform for patients
to become active members of their health care team. Digital
health technology encompasses clinical tools, advanced
statistical algorithms, cloud computing, and artificial intelligence
[9]. Research on digital technology can evaluate innovative
approaches to improve care through PRO measures. The
bidirectional transfer of data through smartphones offers an
unprecedented method to collect PROs across the entire course
of a cancer patient’s journey, allowing providers to monitor
long-term outcomes. However, the translation of evidence-based
health care interventions onto a digital platform should be
evaluated to determine whether it is feasible and effective digital
health technology [10-12].
The objective of this study was to test the feasibility and
acceptability of Strength Through Insight, a digital health app
collecting electronic PROs (ePROs) in patients with prostate
cancer, and to examine patient perspectives to help create future
digital health interventions. Apple’s ResearchKit empowers
medical research by creating a mobile infrastructure for
informed consent, surveys, and real-time active tasks (spatial
memory, voice tests, motor activities, sleep-wake cycle,
nutrition, and daily step counts) using the iPhone sensors and
capabilities [13]. Strength Through Insight, a smartphone app
built on the ResearchKit platform, aimed to explore the
feasibility and acceptability of smartphone devices as a digital
health tool to collect PROs for patients with cancer in the health
care setting through a mixed methods approach.
To our knowledge, this is the first study piloting an ePRO using
the ResearchKit smartphone app platform for patients with
prostate cancer. The study (1) tested the feasibility of collecting
ePROs via a digital health app, with a validated HRQoL
questionnaires for patients undergoing prostate cancer treatment,
and (2) analyzed patient attitudes and perceptions through
qualitative interviews to identify reoccurring themes that address
facilitators and barriers of adopting digital health to best support
future design and implementation of digital health technology.
We hypothesized that more than 80% of patients will complete
60% of the HRQoL questionnaires, once a week for a period of
12 weeks, proving the feasibility of ePROs in a smartphone
app.
Methods
Procedures
This feasibility study was conducted at the Sidney Kimmel
Cancer Center at Thomas Jefferson University Hospital (TJUH).
Following TJUH institutional review board approval, potential
participants were identified through a database maintained by
the Sidney Kimmel Cancer Center.
The study was made available on the ClinicalTrials.gov [14]
and on the Sidney Kimmel Cancer Center’s website in a listing
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of ongoing clinical trials. Potential participants were also
recruited by research staff at TJUH in accordance with
board-approved methods. Participating clinicians reviewed their
patient lists and identified eligible patients who were then
telephoned by a research staff member to confirm eligibility.
Eligibility was confirmed by verbal confirmation of inclusion
and exclusion criteria that were also available as part of the
consent in the smartphone app. Eligible patients received
detailed information regarding the study and, if interested, were
sent a next steps document explaining possible risk and benefits,
study expectations, expected time to complete, how to download
the app, answer the questionnaire, configure settings (ie, cellular
data and push notifications), set reminders, and encouraging
reporting of their patient outcome via the HRQoL questionnaire.
The document also included information on how to follow up
with the research team if they felt that they needed additional
support. Participants were required to provide informed consent
for the study through their smartphones, on downloading the
app, before answering any questions. All relevant information,
including objectives of the study, required activities of
participants, study procedures, confidentiality, and privacy of
information, was provided in the consent. Patients with
upcoming scheduled appointments at the cancer center had the
option to meet with research staff during their clinic visit to get
help downloading the app, configure app settings, or complete
assessments.
The study investigators developed patient interview guide
questions based on clinical experience and relevant literature.
The guide consisted of questions regarding patients’ expectations
and experiences throughout prostate cancer treatment, which
was defined for participants as encompassing symptom
management (perceived knowledge about treatment side effects),
patient-physician communication, digital literacy, quality of
life, social media, and patient satisfaction.
Participants
Eligible patients were patients with prostate cancer who were
receiving follow-up care (including follow-up and newly
diagnosed patients). Inclusion criteria included (1) aged 18 years
or older, (2) self-reported ability to speak and read English, (3)
ability to communicate on a touch screen iPhone, (4) willing to
provide signed informed consent, (5) willing and able to comply
with all study activities, and (6) access to Wi-Fi connection or
cellular data. Exclusion criteria included (1) subjects with
concurrent medical or psychiatric condition who may have
precluded participation in this study or completion of
self-administered questionnaires (eg, moderate to severe
dementia and/or severe, uncontrolled schizophrenia or other
conditions that would render them unable to complete a
questionnaire) and (2) cognitive or other impairment (eg, visual)
that would interfere with completing a self-administered
questionnaire on an iPhone.
Measures
The NCI Symptom Management and Health-Related Quality
of Life Steering Committee recommend core sets of PROs to
be routinely incorporated in prostate cancer treatment. This
effort suggested 5 domains for localized prostate cancer (urinary
incontinence, urinary obstruction and irritation, bowel-related
symptoms, sexual dysfunction, and hormonal symptoms) and
4 domains for advanced prostate cancer (pain, fatigue, mental
well-being, and physical well-being) [6]. Participants were
stratified based on the severity of clinical diagnosis and asked
to answer questionnaires that incorporated the recommended
domains and comprehensively covered the multiple areas related
to HRQoL. Patients with localized prostate cancer were asked
to answer weekly questions from survey A, which included the
validated HRQoL tool, 26-item Expanded Prostate Cancer Index
Composite (EPIC-26; urinary incontinence and
irritation/obstruction items, along with bowel, sexual, and
vitality/hormonal domains), and patients with advanced prostate
cancer were asked to answer weekly questions from survey B,
which included the validated HRQoL tools Expanded Prostate
Cancer Index Composite for Clinical Practice (EPIC-CP) and
8-item Functional Assessment of Cancer Therapy Advanced
Prostate Symptom Index (FAPSI-8; urinary incontinence and
irritation/obstruction items, along with bowel, sexual, and
vitality/hormonal; pain; fatigue/lack of energy; weight loss; and
worry domains). The research team determined the frequency
of completing the assessment as once per week over a period
of 12 weeks.
Participants were asked to complete the EPIC demographic
add-on survey in the smartphone app, which included
information on the participant’s ethnicity, marital status,
employment, smoking status, previous treatments for prostate
cancer, other current medical conditions, education, and income.
Participants were then asked to self-select a survey option
(survey A or survey B) based on the stage of their cancer [6].
Patients with localized prostate cancer were asked to answer
weekly questions from survey A, which included the validated
HRQoL tool, EPIC-26 (urinary incontinence and
irritation/obstruction items, along with bowel, sexual, and
vitality/hormonal domains), and patients with
advanced/metastatic prostate cancer were asked to answer
weekly questions from survey B, which included the validated
HRQoL tools EPIC-CP and FAPSI-8 (urinary incontinence and
irritation/obstruction items, along with bowel, sexual, and
vitality/hormonal; pain; fatigue/lack of energy; weight loss; and
worry domains). Patients were then asked to commit to an
estimated 10 to 15-min participation in the study and configured
app settings to allow or deny push notifications to serve as study
reminders. The research team determined the frequency of
completing the assessment as once per week over a period of
12 weeks. Throughout the study’s duration, all participant
information was deidentified and stored using the secure, Health
Insurance Portability and Accountability Act compliant,
CloudMine data repository. Screenshots of the Strength Through
Insight app are shown in Figure 1.
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Figure 1. Screenshot representations of the Strength Through Insight app.
The feasibility of the Strength Through Insight app was
determined by a dichotomous measure of satisfactory completion
(defined as 60% of weekly questions over a 3-month period).
The rate of satisfactory completion was estimated along with a
1-sided exact 95% CI. The method is considered feasible if the
lower bound of the CI is above 0.7. Acceptability of Strength
Through Insight was determined through patient opinions,
regarding ease of use, satisfaction, and impact on cancer care.
Patient Interviews
Participants were asked to take part in guided interviews via
telephone or in-clinic during visits before completing their first
assessment. Separate interviews were held at the end of the
study to facilitate feedback on Strength Through Insight and
open discussion of topics, such as symptom management,
attitude toward ePRO collection, or preferred method of
reporting to elicit patient opinion on acceptability. Participants
were asked to self-report their digital literacy as having a high
digital literacy level (defined as the ability to use, understand,
evaluate, and analyze information from multiple formats from
a variety of digital sources) or low digital literacy level (defined
as only having the ability to gather information on the internet).
Interviews were conducted by a moderator who had previously
received research training from an experienced qualitative health
teacher. Moderators were not affiliated with the patient’s
oncology care team. Content analysis of interviews provided
common themes, illustrating the informational needs and
concerns regarding remote PROs and digital health technology.
Pre- and postinterview questionnaires are provided in
Multimedia Appendices 1 and 2.
Results
Participants
A total of 29 patients with prostate cancer participated in the
study from August 1, 2016, to December 31, 2017. The main
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reason for ineligibility was because of owning an Android
device, and common causes for participant refusal were
unwillingness to download the app, unable to remember iOS
password (required to download apps), lack of knowledge
concerning apps, and concern of data security. As shown in
Table 1, the median age of participants was 55 years (range
45-70 years). The majority of participants were white, married,
completed college or beyond, digital literacy of Health 2.0, and
reported a current annual household income of US $30,001 to
US $100,000. Overall, 26 (89%) reported a diagnosis of
localized prostate cancer.
Table 1. Sociodemographic and clinical characteristics of participants (N=29).
ValuesCharacteristics
55 (45-70)Age (years), median (range)
Race, n (%)
29 (100)White
Marital status , n (%)
19 (66)Married
Education, n (%)
29 (100)College
Annual household income, n (%)
29 (100)≥$30,000
Diagnosis, n (%)
25 (86)Localized prostate cancer
4 (14)Advanced prostate cancer
Digital health literacy level, n (%)
8 (27)High
Measures
Quantitative Evaluation: Feasibility (Assessment of
Satisfactory Completion)
A total of 29 participants enrolled in the study. Of these 86%
(25/29) reached satisfactory questionnaire completion (defined
as completion of 60% of weekly questions over 12 weeks). The
lower bound of the exact 1-sided 95% CI was 71%, exceeding
the 70% feasibility threshold. All participants were able to
complete informed consent through the smartphone app. Patterns
of missing data showed a decline in responses after week 6.
Moreover, 3 participants reported technical issues (app randomly
closing/needing to restart the app) as the main reason for missing
questions. Of 29, 90% (26/29) participants self-identified with
localized disease chose to opt in push notifications. These
participants reported push notifications to be an effective tool
as a passive reminder to monitor their health. However, patients
with advanced disease preferred not to have push notifications
because of the patient belief that the notifications served as
reminders of their health status or poor quality of life.
Qualitative Evaluation: Acceptability (Use, Satisfaction,
and Impact on Care)
Overall, 72% (21/29) involved in testing the feasibility of the
Strength Through Insight app were a part of the guided
interviews. Representative patient quotes are presented in
Textbox 1. All patients reported that using Strength Through
Insight is easy or equivalent compared with completing a paper
copy of the questionnaire. Most participants cited text messaging
as their preferred method of reporting symptoms. Although
most patients did not express a preferred recall or frequency to
report symptoms (cited wanting to report symptoms when they
experience side effects and not by an unpredictable time point),
several participants expressed bother in reporting symptoms
too frequently. Reasons for skipping weekly questionnaire
included lack of adequate time in personal schedules, lack of
perceived value, technical problems, and issues with
frequency/recall. Although no patients recalled discussing their
assessment report during clinic visits, patients reported that an
increase in personal awareness of symptoms facilitated increased
communication with caregivers, families, and friends rather
than providers. Participants expressed a desire for more
personalized questions and noted skipping questions if
symptoms did not apply, suggesting the need for identifying a
patient’s high priority concerns and symptoms to reduce the
burden on patients completing questionnaires.
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Textbox 1. Representative participant responses to interview questions.
• “Every time I saw the notification on my phone, even if I didn’t automatically go to the app and answer the questionnaire, it made me think of
how I’m doing. And if I had a question about something I was feeling, I go to Dr. Google and search for my symptoms and look at forums from
people to see if I can find someone like me.”
• “I thought it was great! I would be interested on using it for the rest of my treatment because you can’t remember everything, it’s hard to bring
up anyways because my visits are so fast paced. I think my doctor gets really defensive every time I come in with my sheets.”
• “My wife and I actually answered the questions together as a little ritual at the end of the week. We had long talks about some of it because she
made me change my answers to some questions.”
• “Some of the questions were just too general or repetitive. It wasn’t specific to me and I wish there were more questions about my pain management.
I had issues that were worsened by surgery.”
Patient Interviews
Analysis of interview data revealed 4 dominant digital health
themes: (1) the value of emotional support and wellness in
cancer treatment, (2) rise of social patient advocacy in online
patient communities (OPCs) and networks, (3) concerns over
privacy and privacy as a social norm, and (4) the need for
personalized digital health to improve patient engagement.
Theme 1: The Value of Emotional Support and Wellness
in Cancer Treatment
Analysis revealed repeated reference to how Strength Through
Insight and similar apps are fueled by questions specifically
relating to symptoms and AEs and either do not include or only
briefly discuss wellness. Most participants mentioned a lack of
confidence and awareness in responding to questions outside
disease and treatment and criticized apps for undermining the
value of emotional support. A few participants specifically noted
their desire to invest in mental and emotional well-being more
than tending to treatment symptoms was emphasized. Similar
interview responses pointed to the lack of questions focused on
psychosocial or emotional support in the self-management of
cancer treatment.
Theme 2: The Rise of Social Patient Advocacy in Online
Patient Communities and Networks
The particular role of social media through OPCs and networks
was emphasized as a recurring topic. Several participants
identified the use of patient communities, such as Facebook
groups, the smartphone app Belong, or content communities,
such as Reddit, as the main environment to obtain trusted
information and connect with other cancer patients and
caregivers. Some patients reported the use of online communities
over education websites, such as WebMD. In addition, a few
patients reported the preference of these platforms over clinic
visits with providers because fellow cancer patients are seen as
experts and offer more and better information.
Theme 3: Concerns Over Privacy as a Social Norm
Nearly all participants emphasized a concerning issue of how
patient-generated data would be used in the future. Participants
identified the lack of transparency regarding current and future
use of data as a major concern. Several participants also noted
that despite potential disagreement on how information will be
used or clarity of data ownership, they are likely to consent to
health apps regardless because they will not be able to benefit
from digital health technology otherwise.
Theme 4: The Key to Driving Patient Engagement:
Personalization
Almost all patients reported predictive information as an
encouragement to participate in their health care and
acknowledged a desire for the app to be supported through
predictive analytics to help drive engagement and healthy
behavior change. Several participants specifically asked for an
app upgrade that included a data summary component, showing
data analytics to capture a higher level of detail necessary to
predict and personalize symptoms if asked to continue app use.
A summary of the qualitative themes has been illustrated in
Textbox 2.
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Textbox 2. Summary of qualitative themes.
Theme 1: The value of emotional support/wellness in cancer treatment
• “I’d rather an app pay attention to how I’m doing emotionally. Weeks go by and I still end up sleeping the day or weekend away because I’m
depressed and tired. I avoided seeing anyone and used symptoms I didn’t even have as an excuse.”
• “I don’t know if I was depressed. I’m a proud person and didn’t let anyone know how I was feeling really. But my doctor didn’t even ask. Maybe
they need input from other departments.”
Theme 2: The power online patient communities and networks
• “I’ve changed doctors three times, so I know I like my doctor. But I was disappointed because he made me feel confident that I would only
experience certain symptoms. Then 3-4 months down the road, I never thought I would have the pain or some side effects I have now. I wasn’t
told of anything really.”
• “I go on there because I’m interested and want to know more and those are the people I want to talk to. They make me feel like I can take my
life back and move on.”
Theme 3: Privacy as a social norm
• “It’s hard to trust. We don’t have the same type of security on the internet than we do in the real-world. Especially with companies, I don’t believe
they have my best interest in mind. I don’t see my opinion changing.”
Theme 4: Desire for personalized patient engagement
• “Without some kind of data analysis, I feel like I’m just the product giving you information, not the consumer.”
Discussion
Digital Health: Personalizing Health Care
The aim of this study was to explore the feasibility and
acceptability of collecting ePROs using validated HRQoL
assessment tools through a smartphone app in adult men
throughout their course of treatment for prostate cancer. This
study found that 86% (25/29) of participants reached satisfactory
questionnaire completion (defined as completion of 60% of
weekly questions over 12 weeks), proving the feasibility of
collecting ePROs through a digital health app. Patients reported
skipping domain-specific questions (urinary incontinence and
irritation/obstruction items, along with bowel, sexual, and
vitality/hormonal domains) that did not apply to the particular
individual. Although higher completion rates over time would
be desirable, the study was unable to observe this. This may be
because of the lack of feedback to the user regarding their
previous answers to the questionnaire. In this regard, the study
did not originally consider patient feedback and was one of the
learning points the authors were able to extract from this study.
Overall, the use of ePROs may improve the quality of routine
cancer care by expediting the detection of severe or disabling
toxicities [2,15]. Although patients reported facilitated
communication between patients and caregivers, the lack of
increased communication between patient and provider suggests
the requirement for an educational support tool. Patients may
need to be educated on the best practices of self-monitoring and
management of cancer to understand how to manage lifestyle
choices to improve outcomes. This is consistent with other
studies on patient empowerment in prostate cancer, which
identified the need for provider support for the self-management
of prostate cancer and social networks as an important resource
that could be integrated into interventions [16,17].
Patient Acceptance
A primary theme that emerged from the interviews emphasized
the value of emotional support and wellness in cancer treatment.
Patient interviews highlighted the importance of emotional
well-being as an unaddressed side effect of cancer treatment
that is dealt with every day, as opposed to the appearance of
occasional symptoms. This demonstrates another impactful way
digital health can deliver care to meet a patients’ need within
an empowerment framework.
A second major theme was concerned with the importance of
providers to engage patients in participatory medicine with
shared decision making. As a result of this lack of engagement,
patients have resorted to social networking platforms such as
OPCs. OPCs and networks are known for the arrangement and
abundance of information, which enable patients to make
treatment decisions that correspond with their long-term goals
[18]. This research adds evidence to the emerging trend of
community-based social media platforms as a common way for
patients to self-manage their health conditions [19]. Social
cognitive theory along with social network analysis suggests
patients are influenced by OPCs because of the social support
received from online peers and a patient’s self-reflection. For
example, in a recent qualitative pilot study, a Facebook support
group was created for liver transplant patients to use in a virtual
community forum. The study examined the effect of the OPC
on patient engagement and demonstrated an overall positive
impact on patient care, and the main motivation for joining the
group was reported to provide or receive support from other
patients [19]. In a poststudy survey, patients cited their primary
reason for participating in the Facebook group was to provide
and receive support from other patients [19].
A third major theme that emerged puts forward an important
fundamental question in digital health and how patients can
benefit from data while protecting their privacy. Patient concerns
over privacy, confidentiality, and control of data represent a
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growing recognition that patient-generated data from digital
health tools can potentially be used for wanted and unwanted
outcomes. Without public policy regulation concerning the
ownership and responsibility for patient-generated data, digital
health continues to lack transparency over the control of data,
along with its implication for advanced analytics [20,21]. For
example, several smartphone apps’ default option benefits data
collection by effectively setting the default to opt-in rather than
opt-out, granting apps’ access to sensors and data to collect
private information (location data, Web browser history, and
photos).
A fourth major theme indicated the inefficiency of digital health
interventions unless appropriately acted on by patients. Nearly
all patients reported a desire to become more involved with
their health care through data personalization and predictive
analytics. Lessons learned from the compliance rate of Strength
Through Insight suggest that by combining objective measures
of disease while incorporating the perspective of the patient,
predictive analytics could increase participation. This requires
digital health apps to convert patient-generated data into a
functioning algorithm that factors and combines data elements
to produce a useful prediction [22,23]. ePROs that include
personalized reporting measures with symptomatic and
psychometric properties integrated into prediction models can
potentially deliver faster more accurate insights to support
medical decision making [24,25]. The lack of patient
engagement is a specific challenge that prevents ePROs from
being integrated and used in decision making. As researchers
use digital health to leverage advanced machine learning
algorithms, digital health interventions should also be used to
educate patients to better understand and control their own risk
and learn how to appropriately act on implications provided in
personalized statistics [26]. Patients, as consumers of health
care, are the ultimate users and stakeholders of digital health
technology, and future research must identify ways to best
engage patients and caregivers.
A limitation of the study included the lack of a diverse patient
population, which may not be representative of all patients with
prostate cancer. The limited population may be reflected of a
digital divide because most participants were self-reported to
be White, educated, wealthier, and with a high digital literacy.
The requirement of an iOS device also made several interested
patients ineligible because of technology restrictions. The app
was also built before Apple’s most recent announcement for
the new capability of iOS 11.3 in CareKit, which enables
patients to download laboratory results, allergies, immunizations,
medications, procedures, and vitals from hospitals. Other
limitations to this study may a higher level of patient motivation
from the participants compared with the average patient, in
which these patients were more personally inspired to complete
the tasks. This may have also led to a secondary bias in the
patient’s choice to participate in the study interviews, as
previous studies have suggested that prostate cancer patients
may be more compliant with PROs than other cancer patients
who have more complex care (eg, head and neck cancer
patients). Finally, the study used the validated HRQoL tools
EPIC-26, EPIC-CP, and FAPSI-8, which were validated to be
used on a monthly basis, and Strength Through Insight app’s
mode of asking patients to answer questionnaires on a weekly
basis instead.
A Path Forward
In the last few years, the health care industry has been promoting
the concept of providers and patients collaborating and
communicating with each other as a powerful tool. This has led
to an evolving model of consumerism and a desire of patients
to become engaged in their own health care decisions, delivery,
and interactions. As the digital era progresses, digital health
may serve as an enabler of patient-provider engagement,
extending care beyond the confines of the hospital system and
meeting consumers on their own terms. Digital platforms can
engage consumers in a variety of ways, including tracking
medical progress, treatment adherence, reminders and
scheduling, and communications and providing the ability to
capture more comprehensive data for analysis. However, despite
the benefits of desire, many digital health technologies face the
challenge of personalization, as health care has historically taken
a one size fits all approach to patient engagement using the same
context and communication channel for every patient. Future
technology must focus on each patient as a unique individual,
with his or her own motivations, priorities, and communication
preferences. Moreover, the health care industry has the
opportunity to improve on traditional mass approaches to patient
communication by leveraging lessons learned in both the retail
and financial industries [27,28]. Future digital health apps should
not only focus on the development of technology but use health
behavior and belief models to facilitate design techniques that
incorporate patient perspectives to prompt behavior change.
Conclusions
The health care community has long recognized the value of a
patients’ input in describing their own experiences, which has
led to the growing use of ePROs to improve the efficiency of
data collection and provide new opportunities to bring
meaningful evidence back to patients and providers in innovative
ways. This research provided an in-depth perspective on the
different aspects of implementing ePROs on a digital health
platform. To our knowledge, this was the first study piloting an
ePRO using the ResearchKit smartphone app platform for
patients with prostate cancer and expands on the research
proving the feasibility and rigor of ePROs. With this, the true
value of digital health, as a social and behavioral science,
augmented with technology, can begin to contribute to
population health management, as it shapes psychographic
segmentation by demographic, socioeconomic, health condition,
or behavioral factors to group patients by their distinct
personalities and motivations, which influence their choices.
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